BRCA1 Antikörper (AA 445-620)
Kurzübersicht für BRCA1 Antikörper (AA 445-620) (ABIN6936512)
Target
Alle BRCA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Bindungsspezifität
 - AA 445-620
 - 
                                            
Spezifität
 - This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40 % of inherited breast cancers and more than 80 % of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene.
 - 
                                            
Kreuzreaktivität (Details)
 - Human.
 - 
                                            
Aufreinigung
 - 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
 - 
                                            
Immunogen
 - Recombinant human BRCA1 protein fragment (around aa445-620) (exact sequence is proprietary)
 - 
                                            
Isotyp
 - IgG1 kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        
Known_Application: Immunohistochemistry (Formalin-fixed) (2-5 μg/mL for 60 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.
Positive_Control: A431 or HeLa cells. Breast, Ovarian or Renal Cell Carcinoma.
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Konzentration
 - 1.0 mg/mL
 - 
                                            
Buffer
 - Prepared in 10 mM PBS, WITHOUT BSA and Azide.
 - 
                                            
Konservierungsmittel
 - Azide free
 - 
                                            
Lagerung
 - -20 °C,-80 °C
 - 
                                            
Informationen zur Lagerung
 - Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
 - 
                                            
Haltbarkeit
 - 24 months
 
 - 
                                            
 - 
    
- BRCA1 (Breast Cancer 1 (BRCA1))
 - 
                                            
Andere Bezeichnung
 - BRCA1
 - 
                                            
Hintergrund
 - 
                        BRCA1, Breast and ovarian cancer susceptibility protein 1, Breast Cancer 1 Early Onset, Breast cancer type 1 susceptibility protein, BROVCA1, IRIS, PNCA4, PPP1R53, Protein phosphatase 1 regulatory subunit 53, PSCP, RING finger protein 53, RNF53,BRCA1 (Breast Marker)
Cellular localisation: Cytoplasmic and Nuclear - 
                                            
Molekulargewicht
 - 220kDa
 - 
                                            
Gen-ID
 - 672, 194143
 - 
                                            
UniProt
 - P38398
 - 
                                            
Pathways
 - Zellzyklus, DNA Reparatur, Intracellular Steroid Hormone Receptor Signaling Pathway, Positive Regulation of Response to DNA Damage Stimulus
 
Target
 -